Phase II Study of Cediranib in Patients with Malignant Pleural Mesothelioma: SWOG S0509
Year: 2011
Type: article
Study design: Clinical Trial
Source: Journal of Thoracic Oncology
Authors: Linda L. Garland, Kari Chansky, Antoinette J. Wozniak, Anne S. Tsao, Shirish M. Gadgeel, Claire F. Verschraegen, Marco A. DaSilva, Mary Redman, David R. Gandara
Institutions: University of Arizona, SWOG Cancer Research Network, Wayne State University, The Barbara Ann Karmanos Cancer Institute, The University of Texas MD Anderson Cancer Center, University of New Mexico, UNM Comprehensive Cancer Center, UC Davis Comprehensive Cancer Center, University of California, Davis
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Awards: G1343089328, G1545560008, U10 Full Member Application Affiliated with SWOG, G1790576020, G1958973285, G1985252453, G2043432835, G2320693132, G2345882982, G2419449687, G2435896781, G2485941414, G268786457, SOUTHWEST ONCOLOGY GROUP STATISTICAL CENTER, G3144944009, UCDCCC NCTN U10 Program, Southeast Cancer Control Consortium, Inc, G3484997517, G3521018462, G3647597407, G36541222, G3710026009, G379387698, G3827208107, G3939550896, G425646771, Southwest Oncology Group, G444114835, G4719029039, G5264753430, G543303160, G5566132837, G6723594983, G7222907299, G7520596819, G7860541851, G7926913928, G8006406963, G8116866424, G8156375866, G8937348795, G937543590, G971274320
OpenAlex ID: W2005564013
